搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 天
FDA批准Niktimvo用于治疗慢性移植物抗宿主病
WILMINGTON, Del. 和 WALTHAM, Mass. - Incyte (NASDAQ:INCY) 和 Syndax Pharmaceuticals (NASDAQ:SNDX) 今天宣布,美国食品和药物管理局(FDA)最近批准了Niktimvo™(axatilimab-csfr)用于治疗体重至少40公斤的成人和儿童患者在两线系统治疗失败后的慢性移植物抗宿主病(GVHD)。这一宣布紧随 ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Left note, bail denied
Didn't authorize apology
Returning Indian antiquities
Colo. shooter found guilty
1951 kidnap victim found
Reds fire manager
Makes emergency landing
Astronauts return to Earth
Daylight saving time
To meet Vietnamese pres
No govt. shutdown for now
Robinson loses key staff
FBI: Violent crime declined
Visits US ammunition plant
SpaceX plans Mars missions
Tech ban proposed
No. 1 at box office again
Dolphins legend Morris dies
San Francisco homelessness
Donlon's homes searched
Bulls escape MA rodeo
Economic speech this week
More troops to Middle East
Gulf Coast storm warning
Co-founder testifies
California sues ExxonMobil
Closing last full-size store
Iran coal mine blast
Makes new offer to union
NE electoral change blocked
反馈